Literature DB >> 18623879

Skeletal muscle involvement in systemic sclerosis.

J M Thompson1, R Bluestone, E G Bywaters, J Dorling, M Johnson.   

Abstract

Entities:  

Year:  1969        PMID： 18623879      PMCID： PMC1031178          DOI： 10.1136/ard.28.3.281

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  DIABETIC MICROANGIOPATHY IN HUMAN TOES; WITH EMPHASIS ON THE ULTRASTUCTURAL CHANGE IN DERMAL CAPILLARIES.

Authors:  B B BANSON; P E LACY
Journal:  Am J Pathol       Date:  1964-07       Impact factor: 4.307

2.  THE ESTIMATION OF MEAN POTENTIAL DURATION IN ENDOCRINE MYOPATHY.

Authors:  D A YATES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-10       Impact factor: 10.154

3.  Electromyographic findings in scleroderma.

Authors:  I HAUSMANOWA-PETRUSEWICZ; A KOZMINSKA
Journal:  Arch Neurol       Date:  1961-03

4.  Histological lesions of muscle in dermatomyositis; differentiation from related musculo-cutaneous syndromes.

Authors:  P LE COULANT; L TEXIER
Journal:  Br J Dermatol       Date:  1957-09       Impact factor: 9.302

5.  Histochemical demonstration of acid phosphatases with naphthol AS-phosphates.

Authors:  M S BURSTONE
Journal:  J Natl Cancer Inst       Date:  1958-09       Impact factor: 13.506

6.  Muscle action potentials in myopathies with special regard to progressive muscular dystrophy.

Authors:  P PINELLI; F BUCHTHAL
Journal:  Neurology       Date:  1953-05       Impact factor: 9.910

7.  Electron microscopic observations on skeletal muscle in diffuse scleroderma.

Authors:  R Michalowski; J Kudejko
Journal:  Br J Dermatol       Date:  1966-01       Impact factor: 9.302

8.  An electron-microscope study of muscle degeneration and vascular changes in polymyositis.

Authors:  S A Shafiq; A T Milhorat; M A Gorycki
Journal:  J Pathol Bacteriol       Date:  1967-07

9.  The cytochemical localization of oxidative enzymes. I. Diphosphopyridine nucleotide diaphorase and triphosphopyridine nucleotide diaphorase.

Authors:  D G SCARPELLI; R HESS; A G PEARSE
Journal:  J Biophys Biochem Cytol       Date:  1958-11-25
  9 in total
  8 in total

1.  Methotrexate therapy in polymyositis.

Authors:  F C Arnett; J C Whelton; T M Zizic; M B Stevens
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

2.  Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.

Authors:  R Bluestone; R Grahame; V Holloway; P J Holt
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

Review 3.  Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Authors:  Andrew L Mammen
Journal:  Nat Rev Neurol       Date:  2011-06-08       Impact factor: 42.937

4.  Clinical and laboratory features of scleroderma patients developing skeletal myopathy.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2004-08-20       Impact factor: 2.980

Review 5.  Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Authors:  Ulrich A Walker; Philip J Clements; Yannick Allanore; Oliver Distler; Chester V Oddis; Dinesh Khanna; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

6.  Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology.

Authors:  Elise Siegert; Akinori Uruha; Carsten Dittmayer; Werner Stenzel; Hans-Hilmar Goebel; Corinna Preuße; Vincent Casteleyn; Felix Kleefeld; Rieke Alten; Gerd R Burmester; Udo Schneider; Jakob Höppner; Kathrin Hahn
Journal:  Acta Neuropathol       Date:  2021-04-17       Impact factor: 17.088

7.  Impaired skeletal muscle microcirculation in systemic sclerosis.

Authors:  Sasan Partovi; Anja-Carina Schulte; Markus Aschwanden; Daniel Staub; Daniela Benz; Stephan Imfeld; Björn Jacobi; Pavel Broz; Kurt A Jäger; Martin Takes; Rolf W Huegli; Deniz Bilecen; Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2012-10-04       Impact factor: 5.156

8.  Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology.

Authors:  Kavish J Bhansing; Martin Lammens; Hanneke K A Knaapen; Piet L C M van Riel; Baziel G M van Engelen; Madelon C Vonk
Journal:  Arthritis Res Ther       Date:  2014-05-13       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.